Found: 39
Select item for more details and to access through your institution.
Why we still need drugs for COVID‐19 and can't just rely on vaccines.
- Published in:
- Respirology, 2022, v. 27, n. 2, p. 109, doi. 10.1111/resp.14199
- By:
- Publication type:
- Article
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 1, p. 49, doi. 10.1002/eji.201444722
- By:
- Publication type:
- Article
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Calretinin as a blood-based biomarker for mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060951
- By:
- Publication type:
- Article
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase.
- Published in:
- International Immunology, 2012, v. 24, n. 6, p. 357, doi. 10.1093/intimm/dxs005
- By:
- Publication type:
- Article
Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.
- Published in:
- International Immunology, 2008, v. 20, n. 11, p. 1467, doi. 10.1093/intimm/dxn104
- By:
- Publication type:
- Article
Generation of an antitumour immune response to a murine mesothelioma cell line by the transfection of allogeneic mhc genes.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 2, p. 212, doi. 10.1002/ijc.2910590213
- By:
- Publication type:
- Article
Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.
- Published in:
- International Journal of Cancer, 1991, v. 47, n. 2, p. 285, doi. 10.1002/ijc.2910470219
- By:
- Publication type:
- Article
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
- Published in:
- Scientific Reports, 2016, p. 32643, doi. 10.1038/srep32643
- By:
- Publication type:
- Article
Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103025
- By:
- Publication type:
- Article
Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026515
- By:
- Publication type:
- Article
Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0006982
- By:
- Publication type:
- Article
Serologic Responses in Patients with Malignant Mesothelioma.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2000, v. 22, n. 5, p. 550, doi. 10.1165/ajrcmb.22.5.3930
- By:
- Publication type:
- Article
Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.
- Published in:
- Respiratory Research, 2001, v. 2, p. 119, doi. 10.1186/rr46
- By:
- Publication type:
- Article
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3249, doi. 10.1007/s00262-021-02934-3
- By:
- Publication type:
- Article
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1219, doi. 10.1007/s00262-008-0628-9
- By:
- Publication type:
- Article
Functional endogenous cytotoxic T lymphocytes are generated to multiple antigens co-expressed by progressing tumors; after intra-tumoral IL-2 therapy these effector cells eradicate established tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 8, p. 933, doi. 10.1007/s00262-005-0086-6
- By:
- Publication type:
- Article
Cross-priming in health and disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020).
- Published in:
- Advanced Science, 2020, v. 7, n. 9, p. 1, doi. 10.1002/advs.201903410
- By:
- Publication type:
- Article
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer.
- Published in:
- Advanced Science, 2020, v. 7, n. 9, p. 1, doi. 10.1002/advs.201903410
- By:
- Publication type:
- Article
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
- Published in:
- Clinical Proteomics, 2016, v. 13, p. 1, doi. 10.1186/s12014-016-9103-3
- By:
- Publication type:
- Article
Climbing Mount Kilimanjaro in a blizzard.
- Published in:
- Medical Journal of Australia, 2004, v. 181, n. 11/12, p. 646, doi. 10.5694/j.1326-5377.2004.tb06504.x
- By:
- Publication type:
- Article
Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum.
- Published in:
- Disease Markers, 2013, v. 35, n. 2, p. 119, doi. 10.1155/2013/874212
- By:
- Publication type:
- Article
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0245-7
- By:
- Publication type:
- Article
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
- Published in:
- Frontiers in Toxicology, 2024, p. 1, doi. 10.3389/ftox.2024.1373003
- By:
- Publication type:
- Article
Research Article CD4<sup>+</sup> T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells.
- Published in:
- Immunology & Cell Biology, 2004, v. 82, n. 2, p. 103, doi. 10.1046/j.0818-9641.2004.01233.x
- By:
- Publication type:
- Article
The induction of immune responses to murine malignant mesothelioma by IL-2 gene transfer.
- Published in:
- Immunology & Cell Biology, 1997, v. 75, n. 4, p. 356, doi. 10.1038/icb.1997.55
- By:
- Publication type:
- Article
Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Doctor in pain — learning as a patient.
- Published in:
- Medical Journal of Australia, 1992, v. 156, n. 9, p. 669, doi. 10.5694/j.1326-5377.1992.tb121488.x
- By:
- Publication type:
- Article
Doctor in pain — learning as a patient.
- Published in:
- Medical Journal of Australia, 1992, v. 156, n. 5, p. 355, doi. 10.5694/j.1326-5377.1992.tb139799.x
- By:
- Publication type:
- Article
After the Fellowship — basic research?
- Published in:
- Medical Journal of Australia, 1990, v. 153, n. 11/12, p. 692, doi. 10.5694/j.1326-5377.1990.tb126325.x
- By:
- Publication type:
- Article
Nitrofurantoin‐induced interstitial pulmonary fibrosis.
- Published in:
- Medical Journal of Australia, 1983, v. 1, n. 2, p. 72, doi. 10.5694/j.1326-5377.1983.tb136042.x
- By:
- Publication type:
- Article
Immunotherapy and chemotherapy--a practical partnership.
- Published in:
- 2005
- By:
- Publication type:
- research
CD8α.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 6, p. 1617, doi. 10.1002/eji.200940153
- By:
- Publication type:
- Article